Literature DB >> 14707524

Tall stature and progressive overweight in mitochondrial encephalopathy.

E Morava1, F A Hol, A Janssen, J Smeitink.   

Abstract

We describe two children carrying an inherited T899C mutation in the mitochondrial ATPase 6 gene with mild encephalopathy and normal postnatal growth followed by tall stature and obesity. No familial tall stature, endocrine anomaly or advanced skeletal age were present. Failure to thrive is a characteristic finding in most patients with a mitochondrial disease. Our observations suggest that children with encephalomyopathy, even in the presence of a significant clinical overgrowth, should be screened for a possible defect in oxidative phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14707524     DOI: 10.1023/b:boli.0000005647.71704.25

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  3 in total

1.  Comparative biochemical studies of ATPases in cells from patients with the T8993G or T8993C mitochondrial DNA mutations.

Authors:  M E Vázquez-Memije; S Shanske; F M Santorelli; P Kranz-Eble; D C DeVivo; S DiMauro
Journal:  J Inherit Metab Dis       Date:  1998-12       Impact factor: 4.982

2.  Phenotypic variability in a family with a mitochondrial DNA T8993C mutation.

Authors:  Y Suzuki; T Wada; T Sakai; Y Ishikawa; R Minami; N Tachi; S Saitoh
Journal:  Pediatr Neurol       Date:  1998-10       Impact factor: 3.372

3.  Mitochondrial DNA 8993 (NARP) mutation presenting with a heterogeneous phenotype including 'cerebral palsy'.

Authors:  A Fryer; R Appleton; M G Sweeney; L Rosenbloom; A E Harding
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

  3 in total
  1 in total

1.  Genetic association study of common mitochondrial variants on body fat mass.

Authors:  Tie-Lin Yang; Yan Guo; Hui Shen; Shu-Feng Lei; Yong-Jun Liu; Jian Li; Yao-Zhong Liu; Na Yu; Jia Chen; Ting Xu; Yu Cheng; Qing Tian; Ping Yu; Christopher J Papasian; Hong-Wen Deng
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.